首頁 > 市場調查報告書 > 製藥

疫苗感染疾病

2030 年亞太地區瘧疾治療市場預測 - 區域分析 - 按治療、給藥途徑和配銷通路

市場調查報告書

商品編碼

1510756

2030 年亞太地區瘧疾治療市場預測 - 區域分析 - 按治療、給藥途徑和配銷通路

Asia Pacific Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 88 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年亞太地區瘧疾治療市值為6.3137億美元，預計2030年將達到51.7915億美元；預計2022年至2030年複合年成長率為30.1%。

市場參與者不斷增加的策略性措施推動亞太瘧疾治療市場

瘧疾治療市場的一些主要參與者越來越注重採用各種策略，例如產品創新、發布和批准；研發投資；以及併購以保持競爭力。下面提到了其中一些措施：

2023年，R21/Matrix-M瘧疾疫苗被納入世界衛生組織的預審疫苗清單。根據瘧疾政策諮詢小組和世衛組織免疫策略諮詢專家小組 (SAGE) 的建議，世衛組織建議於 2023 年 10 月引入免疫接種，以預防兒童瘧疾。資格預審是聯合國兒童基金會購買疫苗以及全球疫苗免疫聯盟為其部署提供財政支持的要求，這意味著更多的兒童將獲得疫苗作為對抗瘧疾的重要工具。

2022 年3 月，用於治療特定瘧疾菌株的新藥他非諾喹在澳洲獲得了Medicines for Malaria Venture (MMV) 的許可，該公司與葛蘭素史克(GSK) 共同開發了該藥物，用於兒童和青少年。該藥與廣泛使用的抗瘧藥－氯奎聯合使用。

2021年12月，Zydus Cadila宣布計畫與Medicines for Malaria Venture合作開發其抗瘧藥物ZY19489，並獲得美國FDA批准。據該公司稱，ZY19489的I期試驗證明了其半衰期長，並且具有單劑量治癒瘧疾的潛力。在一項單獨的瘧疾挑戰試驗中，單次口服 ZY19489 後顯示出強烈的抗瘧活性。

2021年1月，GSK、PATH和Bharat Biotech (BBIL)宣布簽署瘧疾疫苗RTS,S/AS01E的產品轉移協議。該協議包括將疫苗 RTS,S 抗原部分的生產轉移給 BBIL，並向 BBIL 授予與瘧疾疫苗相關的所有權利的許可。 GSK 保留疫苗佐劑（AS01E）的生產並供應給 BBIL。

因此，市場參與者的上述策略性舉措預計將為未來幾年的瘧疾治療市場提供成長機會。

亞太地區瘧疾治療市場概況

馬來西亞、印尼、紐西蘭、越南、菲律賓、新加坡和泰國是亞太其他地區的主要國家。其中大多數是低收入和中等收入國家，醫療保健支出較高。根據美國國家傳染病中心 2022 年報告，新加坡每年約有 100-300 例瘧疾病例（80% 間日瘧）是輸入性的。總部位於新加坡區域中心的聯合秘書處促進 APLMA 和亞太消除瘧疾網路 (APMEN) 之間的跨境合作，透過量身定做的解決方案消除亞太地區的瘧疾。

全球健康組織的報告指出，馬來西亞近三分之一（32%）的瘧疾病例發生在馬來西亞半島，其中大部分發生在中部、東南部和北部沿海地區。例如，年輕的職業男性感染瘧疾的風險很高，據報道，近 50% 被診斷出患有瘧疾的馬來西亞人從事農業和其他戶外工作。該計劃包括對疑似瘧疾病例進行 100% 確證檢測、對發現的病例進行強制報告、綜合病媒管理和社區參與，並挑選一批志願初級衛生保健人員並接受瘧疾診斷和治療方面的培訓。此外，馬來西亞是 APMEN 的國家合作夥伴，該網路由 18 個亞太國家和其他利益相關者組成，致力於消除該國的瘧疾。

因此，上述因素將促進該地區瘧疾治療市場的成長。

亞太地區瘧疾治療市場收入及 2030 年預測（百萬美元）

亞太地區瘧疾治療市場區隔

亞太地區瘧疾治療市場根據治療、給藥途徑、配銷通路和國家進行細分。根據治療方法，亞太地區瘧疾治療市場分為學名藥、原廠藥、疫苗等。 2022 年，疫苗領域佔據最大的市場。

就給藥途徑而言，亞太地區瘧疾治療市場分為口服和腸外給藥。 2022年，口腔細分市場佔據了更大的市場。

依配銷通路，亞太瘧疾治療市場分為直接招標、醫院藥局、零售藥局、線上藥局等。 2022 年，直接招標領域佔據最大的市場佔有率。

依國家/地區分類，亞太地區瘧疾治療市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2022 年，亞太地區其他地區主導了亞太地區瘧疾治療市場。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、賽諾菲 SA、GSK Plc、諾華 AG、輝瑞 Inc、AdvaCare Pharma USA LLC 和 Lupin Ltd 是亞太地區瘧疾治療市場的一些領先參與者。

A few major players operating in the malaria treatment market are increasingly focusing on the adoption of various strategies such as product innovations, launches, and approvals; R&D investments; and mergers and acquisitions in order to remain competitive. A few of these initiatives are mentioned below:

In 2023, The R21/Matrix-M malaria vaccine is included in the WHO's list of prequalified vaccines. Following the recommendations of the Malaria Policy Advisory Group and the WHO Strategic Advisory Group of Experts (SAGE) on Immunization, the WHO recommended its introduction in October 2023 to prevent malaria in children. Prequalification is a requirement for UNICEF to purchase vaccinations and for Gavi, the Vaccine Alliance, to provide financial support for their deployment, which means that more children will have access to vaccines as a crucial tool in the fight against malaria.

In March 2022, tafenoquine, a novel drug used to treat a specific strain of malaria, was licensed in Australia by Medicines for Malaria Venture (MMV), which codeveloped the drug with GlaxoSmithKline (GSK) for children and adolescents. The drug is combined with the widely used antimalarial drug-chloroquine.

In December 2021, Zydus Cadila announced the plan to develop its antimalarial drug ZY19489 with Medicines for Malaria Venture, which received US FDA approval. According to the company, the Phase I trial of ZY19489 demonstrated a long half-life and the potential for a single-dose cure for malaria. In a separate malaria challenge trial, strong antimalarial activity was displayed after a single oral dose of ZY19489.

In January 2021, GSK, PATH, and Bharat Biotech (BBIL) declared that a product transfer agreement was signed for the malaria vaccine RTS,S/AS01E. The agreement included transferring the manufacturing of the RTS,S antigen portion of the vaccine and granting a license for all rights related to the malaria vaccine to BBIL. GSK retains production of the vaccine adjuvant (AS01E) and supplies it to BBIL.

Therefore, the abovementioned strategic initiatives by the market players are expected to provide growth opportunities for the malaria treatment market in the coming years.

Asia Pacific Malaria Treatment Market Overview

Malaysia, Indonesia, New Zealand, Vietnam, the Philippines, Singapore, and Thailand are among the major countries in the Rest of Asia Pacific. Most of these are low- and middle-income countries, with high healthcare expenditures. According to the National Centre for Infectious Diseases 2022 report, ~100-300 malaria cases (80% vivax) per annum are imported in Singapore. A joint secretariat headquartered in the regional hub of Singapore facilitates a cross-border collaboration between APLMA and Asia Pacific Malaria Elimination Network (APMEN) to eliminate malaria from Asia Pacific with tailored solutions.

The Global Health Group report states that nearly one-third (32%) of total malaria cases in Malaysia occur in Peninsula Malaysia, and the majority of these are found in the Central, Southeastern, and northern coastal regions. For example, young working males are at high risk of getting infected with malaria, and nearly 50% of Malaysians diagnosed with malaria reportedly work in agriculture and other outdoor jobs. The program includes 100% confirmatory testing of suspected malaria cases, mandatory reporting of detected cases, integrated vector management, and string community participation, with a cadre of volunteer primary healthcare workers selected and trained in malaria diagnosis and treatment. Further, Malaysia is a country partner of the APMEN, a network composed of 18 Asia Pacific countries and other stakeholders working to eliminate malaria in the country.

Thus, the abovementioned factors will foster the growth of the malaria treatment market in this region.

Asia Pacific Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Malaria Treatment Market Segmentation

The Asia Pacific malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the Asia Pacific malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The vaccines segment held the largest market share in 2022.

In terms of route of administration, the Asia Pacific malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the Asia Pacific malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the Asia Pacific malaria treatment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The Rest of Asia Pacific dominated the Asia Pacific malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, AdvaCare Pharma USA LLC, and Lupin Ltd are some of the leading players operating in the Asia Pacific malaria treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights - Malaria

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Malaria Treatment Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Malaria
- 4.1.2 Rising Initiatives to Raise Awareness about Malaria
4.2 Market Restraints
- 4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
- 4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis

5. Malaria Treatment Market - Asia Pacific Market Analysis

5.1 Asia Pacific Malaria Treatment Market Revenue (US$ million), 2022 - 2030

6. Asia Pacific Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

6.1 Overview
6.2 Asia Pacific Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
- 6.3.1 Overview
- 6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
- 6.4.1 Overview
- 6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
- 6.5.1 Overview
- 6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)

7. Asia Pacific Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

7.1 Overview
7.2 Asia Pacific Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
- 7.3.1 Overview
- 7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
- 7.4.1 Overview
- 7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview
8.2 Asia Pacific Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
- 8.3.1 Overview
- 8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
- 8.4.1 Overview
- 8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Retail Pharmacies
- 8.5.1 Overview
- 8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Online Pharmacies
- 8.6.1 Overview
- 8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Malaria Treatment Market - Country Analysis

9.1 Asia Pacific Malaria Treatment Market, Revenue and Forecast to 2030
- 9.1.1 Overview
  - 9.1.1.1 Asia Pacific: Malaria Treatment Market, by Countries
  - 9.1.1.2 Japan
  - 9.1.1.3 Overview
    - 9.1.1.3.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.3.2 Japan: Malaria Treatment Market, by Treatment
    - 9.1.1.3.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.3.4 Japan: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.3.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.3.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.4 India
  - 9.1.1.5 Overview
    - 9.1.1.5.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.5.2 India: Malaria Treatment Market, by Treatment
    - 9.1.1.5.3 India: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.5.4 India: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.5.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.5.4.2 India: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.6 South Korea
  - 9.1.1.7 Overview
    - 9.1.1.7.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.7.2 South Korea: Malaria Treatment Market, by Treatment
    - 9.1.1.7.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.7.4 South Korea: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.7.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.7.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.8 Australia
  - 9.1.1.9 Overview
    - 9.1.1.9.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.9.2 Australia: Malaria Treatment Market, by Treatment
    - 9.1.1.9.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.9.4 Australia: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.9.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.9.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.10 Rest of Asia Pacific
  - 9.1.1.11 Overview
    - 9.1.1.11.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.11.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
    - 9.1.1.11.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.11.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.11.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.11.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies

10. Malaria Treatment Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Cipla Ltd
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi SA
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 GSK Plc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Novartis AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Pfizer Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Service
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 AdvaCare Pharma USA LLC
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Lupin Ltd
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 5. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 8. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 9. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 10. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 12. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 14. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 15. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 16. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 17. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 18. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 19. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 20. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 21. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 22. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 23. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 24. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 25. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 26. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 27. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 28. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 29. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 30. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 31. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 32. Glossary of Terms, Malaria Treatment Market

List Of Figures

Figure 1. Malaria Treatment Market - Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Malaria Treatment Market Revenue (US$ million), 2022 - 2030
Figure 4. Asia Pacific Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. Asia Pacific Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Malaria Treatment Market, 2022 ($Mn)
Figure 19. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in the Malaria Treatment Market